Ravuconazole
Alternative Names: BMS 207147; ER 30346Latest Information Update: 24 Oct 2021
At a glance
- Originator Eisai Co Ltd
- Class Antifungals; Azoles; Benzonitrile; Small molecules
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Aspergillosis; Candidiasis; Histoplasmosis; Mycoses; Onychomycosis
Most Recent Events
- 06 Aug 2007 Discontinued - Phase-I/II for Onychomycosis in Canada (PO)
- 06 Aug 2007 Discontinued - Phase-II for Aspergillosis in USA (unspecified route)
- 06 Aug 2007 Discontinued - Phase-II for Candidiasis in USA (unspecified route)